Literature DB >> 1632467

Overexpression of p53 protein in basal cell carcinomas of human skin.

C R Shea1, N S McNutt, M Volkenandt, J Lugo, P G Prioleau, A P Albino.   

Abstract

Basal cell carcinoma (BCC) of the skin is the most common human cancer, but its molecular-genetic pathogenesis is unclear. In many other types of cancer, mutations of the tumor-suppressor gene p53 occur frequently and may lead to overexpression of a long-lived mutant form of p53 protein. In this study, overexpression of p53 protein was detected immunohistochemically in 30 (83%) of 36 specimens of BCC of the head and neck. The same regions of tumor typically were reactive both with a monoclonal antibody (PAb240) specific for the mutant protein and with one (PAb1801) directed against an epitope common to both wild-type and mutant p53 protein. Keratinocytes of chronically sun-exposed epidermis adjacent to BCCs also focally overexpressed p53 protein in the majority of cases, whereas those of sun-protected buttock skin did not. Mutation of p53 may form an important part of the pathogenetic sequence in a majority of cases of BCC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632467      PMCID: PMC1886589     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

1.  Mutant p53--the commonest genetic abnormality in human cancer?

Authors:  A L Harris
Journal:  J Pathol       Date:  1990-09       Impact factor: 7.996

2.  Cancer statistics, 1991.

Authors:  C C Boring; T S Squires; T Tong
Journal:  CA Cancer J Clin       Date:  1991 Jan-Feb       Impact factor: 508.702

3.  Different tumor-derived p53 mutants exhibit distinct biological activities.

Authors:  O Halevy; D Michalovitz; M Oren
Journal:  Science       Date:  1990-10-05       Impact factor: 47.728

4.  Mutational analysis of the human p53 gene in malignant melanoma.

Authors:  M Volkenandt; U Schlegel; D M Nanus; A P Albino
Journal:  Pigment Cell Res       Date:  1991-02

Review 5.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

6.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.

Authors:  D E Brash; J A Rudolph; J A Simon; A Lin; G J McKenna; H P Baden; A J Halperin; J Pontén
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

7.  Cytogenetic analysis of 33 basal cell carcinomas.

Authors:  F Mertens; S Heim; N Mandahl; B Johansson; O Mertens; B Persson; L Salemark; J Wennerberg; N Jonsson; F Mitelman
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

8.  Nonmelanoma skin cancer mortality. A population-based study.

Authors:  M A Weinstock; H A Bogaars; M Ashley; V Litle; E Bilodeau; S Kimmel
Journal:  Arch Dermatol       Date:  1991-08

9.  Expression of proto-oncogenes in normal and tumor tissues of human skin.

Authors:  Y Ogiso; T Oikawa; N Kondo; N Kuzumaki; T Sugihara; T Ohura
Journal:  J Invest Dermatol       Date:  1988-06       Impact factor: 8.551

10.  Basal cell carcinoma with metastasis. Review of literature.

Authors:  B Safai; R A Good
Journal:  Arch Pathol Lab Med       Date:  1977-06       Impact factor: 5.534

View more
  14 in total

1.  p21 cooperates with DDB2 protein in suppression of ultraviolet ray-induced skin malignancies.

Authors:  Tanya Stoyanova; Nilotpal Roy; Shaumick Bhattacharjee; Dragana Kopanja; Ted Valli; Srilata Bagchi; Pradip Raychaudhuri
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

2.  B-Raf mutations, microsatellite instability and p53 protein expression in sporadic basal cell carcinomas.

Authors:  Angeliki Stamatelli; Angelica A Saetta; Thaleia Bei; Nicolaos Kavantzas; Nicolaos V Michalopoulos; Efstratios Patsouris; Kiriaki Aroni
Journal:  Pathol Oncol Res       Date:  2011-01-28       Impact factor: 3.201

3.  Diagnosis of basal cell carcinoma by infrared spectroscopy of whole blood samples applying soft independent modeling class analogy.

Authors:  Mohammadreza Khanmohammadi; Razieh Nasiri; Keyvan Ghasemi; Simin Samani; Amir Bagheri Garmarudi
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-02       Impact factor: 4.553

4.  Value of p53 protein in biological behavior of basal cell carcinoma and in normal epithelia adjacent to carcinomas.

Authors:  N C Demirkan ; N Colakoglu ; E Düzcan
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

5.  Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.

Authors:  Y Hayashi; N Ishii; C Obayashi; K Jinnai; K Hanioka; Y Imai; H Itoh
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers.

Authors:  A Ziegler; D J Leffell; S Kunala; H W Sharma; M Gailani; J A Simon; A J Halperin; H P Baden; P E Shapiro; A E Bale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Mutational landscape of basal cell carcinomas by whole-exome sequencing.

Authors:  Shyam S Jayaraman; David J Rayhan; Salar Hazany; Michael S Kolodney
Journal:  J Invest Dermatol       Date:  2013-06-17       Impact factor: 8.551

8.  p21CIP1 controls the squamous differentiation response to replication stress.

Authors:  Isabel de Pedro; Jesús Galán-Vidal; Ana Freije; Ernesto de Diego; Alberto Gandarillas
Journal:  Oncogene       Date:  2020-10-23       Impact factor: 9.867

9.  Immunohistochemical detection of p53 protein in cutaneous lesions from transplant recipients harbouring human papillomavirus DNA.

Authors:  I Pélisson; Y Chardonnet; S Euvrard; D Schmitt
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

10.  Immunohistochemical Localization of p53 in Human Thyroid Neoplasms: Correlation with Biological Behavior.

Authors:  Sefik A. Hosal; Robyn L. Apel; Jeremy L. Freeman; Abbas Azadian; Irving B. Rosen; Virginia A. LiVolsi; Sylvia L. Asa
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.